Dec 30, 2013 1:15 pm EST Heat Biologics Announces Its Phase 1/2 Study of HS-410 in Bladder Cancer Is Open for Enrollment
Dec 17, 2013 8:00 am EST Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
Dec 02, 2013 8:05 am EST Heat Biologics, Inc. to Present at 25th Annual Piper Jaffray Healthcare Conference
Nov 25, 2013 8:30 am EST Heat Biologics Successfully Completes Manufacturing of HS-410 to Start Phase 1/2 Bladder Cancer Trial
Nov 14, 2013 9:20 am EST Heat Biologics, Inc. Reports Third Quarter 2013 Financial Results and Provides Clinical Programs Review
Sep 19, 2013 10:00 am EDT Heat Biologics, Inc. to Present at Aegis Capital Corp. 2013 Healthcare Conference